Experience

• • A major international financial investor in the formation of a €1 billion+ global infrastructure fund.
  • Goldman Sachs Asset Management and Pantheon as co-underwriters of CapVest Strategic Opportunities, a €1.2 billion continuation vehicle sponsored by CapVest for the single-asset fund restructuring of its portfolio company, Curium Pharma.
  • LeapFrog Investments in its $500 million partnership with Temasek, including Temasek taking a minority stake in LeapFrog, and a multi-fund investment by Temasek to anchor LeapFrog’s future funds.
  • Pantheon and LGT Capital Partners as lead investors in a continuation vehicle sponsored by Medicxi, a European life sciences investor, involving six preclinical- and clinical-stage assets.
  • Norilsk Nickel in its $500 million Eurobond offering of 2.55% notes due 2025.
  • Exponent in a £125 million preferred equity facility for Exponent Private Equity Partners III, a £1 billion buyout fund.
  • Metric Capital Partners in the formation of MCP Private Capital Fund IV, a €1.2 billion European special opportunities fund.
  • GHO Capital Partners in the formation of GHO Capital Fund II, a €975 million fund which was Europe’s largest ever healthcare fund at the time of closing.
  • HarbourVest Partners as lead investor in the GP-led restructuring of Bridgepoint Capital’s €4.8 billion crisis-era fund, Bridgepoint Europe IV.
  • Norilsk Nickel in its $750 million Eurobond offering of 3.375% notes due 2024.
  • NLMK in its $500 million Eurobond offering of 4.70% notes due 2026.
  • LeapFrog Investments in the formation of LeapFrog Emerging Consumer Fund III, a $700 million emerging markets-focused impact fund.
  • DBAY Advisors in the formation of DouglasBay Capital III Fund, a European fund making investments in small and micro-cap listed companies.
  • Apera Asset Management in the formation of its €750 million private debt platform, focussing on senior secured loans to lower mid-market businesses in German-speaking Europe, France, Benelux, the UK and Northern Europe.
  • Canson in the formation of its $100 million co-investment fund, which will co-invest in the acquisition of a majority stake in the Financial and Risk division of Thomson Reuters.
  • Norilsk Nickel in its up to $2.5 billion syndicated term loan facility with an international syndicate comprising 17 banks and financial institutions.
  • NLMK in its $500 million Eurobond offering of 4% notes due 2024, and a related tender offer for outstanding notes due 2018 and 2019 for the aggregate principal amount of $317 million.
  • Metric Capital Partners in its €100 million subscription facility with Citibank.
  • Nornickel in its $1 billion Eurobond offering of 4.10% notes due 2023.
  • Metric Capital Partners in the formation of MCP Private Capital Fund III, an €850 million European special opportunities fund.
  • NLMK and its U.S. subsidiaries in a $250 million ABL facility.
  • Polyus Gold International in its $500 million Eurobond offering of 4.699% notes due 2022.
  • PartnerRe in its €750 million debut Eurobond offering of 1.25% notes due 2026.
  • NLMK in its $700 million Eurobond offering of 4.5% loan participation notes due 2023, and a related tender offer for its outstanding notes due 2018 and 2019 for the aggregate principal amount of $571 million.
  • Park Square in the formation of Park Square Capital Partners III, a €1.2 billion subordinated debt fund.
  • HarbourVest Partners in its co-investment with IK Investment Partners in the Salad Signature group, a Dutch and Belgian food business.
  • Prudential Financial in its $350 million partnership with LeapFrog Investments, targeting investments in life insurance companies in Africa.
  • NLMK in its $400 million pre-export finance facility.
  • Norilsk Nickel in its $1 billion Eurobond offering of 6.625% notes due 2022.
  • Lannett in its acquisition for $1.23 billion in cash, plus additional contingent consideration, of Kremers Urban Pharmaceuticals, the U.S. specialty generic pharmaceuticals subsidiary of global biopharmaceuticals company UCB.
  • Park Square in the formation of Park Square Capital Credit Opportunities II, a $2.4 billion senior debt programme.
  • NLMK Europe Plate Division in its €250 million revolving collateralized credit facility.
  • AXA in the sale of its mandatory pension business in Hong Kong to the Principal Financial Group.
  • Exponent Private Equity Partners in the formation of Exponent Private Equity Partners III, a £1 billion UK buyout fund.
  • HarbourVest Partners as a selling shareholder, together with Exponent, in the purchase of Trainline by KKR.
  • Knighthead Capital Management in its formation and capitalization of Knighthead Holdings Ltd., a Cayman Islands-based annuity provider.
  • Ares Management in the formation of Ares Europe Real Estate Fund IV, a $1.3 billion Europe real estate fund.
  • Clayton, Dubilier & Rice in tax aspects of its €1.2 billion acquisition of Mauser Group, a leading provider of industrial packaging.
  • A consortium including HarbourVest Partners and Coller Capital, in their secondary purchase of interests in Absa Capital Private Equity Fund I from Barclays Africa Group, formerly known as Absa Capital, as part of a spin-out of Absa Capital Private Equity from the Absa Group.
  • AREA in its formation of its European real estate funds.
  • Eutelsat in its $1.14 billion acquisition of Satélites Mexicanos.